Fundraising FoxFrequency Therapeutics
Woburn, US · Founded 2014 · Delaware corporation · 8 known investors
Find your way into Frequency Therapeutics
Sign up to see every warm intro you have to Frequency Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Frequency Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Frequency Therapeutics was founded in 2014 by David Lucchino and Christopher R. Loose.
Board
Investors · 8
How we know: venBio Partners's portfolio page · Not right? Tell us
How we know: board seat on SEC Form D · drugdeliverybusiness.com · Not right? Tell us
How we know: a partner's Signal profile · drugdeliverybusiness.com · Not right? Tell us
Also in the syndicate · 3
Funding
SEC filings, press & company announcements$136.3M disclosed across 3 of 4 rounds · 2017–2020
- Undisclosed amountSeries BJan 2019
Axil Capital (lead), Taiwania Capital Management (lead), Alexandria Venture Investments, DF Investments, Polaris Founders Capital, Yonjin Capital
Source ↗
▶$42.3MraisedJul 2020 · 18 investors · BiotechnologyRule 506(b)
- Timothy J. BarberichDirector
- Marc A. CohenDirector
- Robert S. LangerDirector
- Dana HiltExecutive Officer
- David L. LucchinoExecutive Officer, Director
- Joel S. MarcusDirector
- Christopher R. LooseExecutive Officer
- Wendy S. ArnoldExecutive Officer
- Richard MitranoExecutive Officer
- Michael HuangDirector
- Carl P. LeBelExecutive Officer
- Offering amount
- $42.3M
- Amount sold
- $42.3M
- Sales commissions
- $2M
- Placement agents
- Cowen and Company, LLC
- First sale
- Jul 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$62MraisedJul 2019 · 80 investors · BiotechnologyRule 506(b)
- Robert S. LangerDirector
- Michael HuangDirector
- Richard MitranoExecutive Officer
- Carl LebelExecutive Officer
- David LucchinoExecutive Officer, Director
- Christopher R. LooseExecutive Officer
- Timothy BarberichDirector
- Joel MarcusDirector
- Marc CohenDirector
- Offering amount
- $62M
- Amount sold
- $62M
- First sale
- Jul 2019
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$32MraisedApr 2017 · 90 investors · BiotechnologyRule 506(b)
- David LucchinoExecutive Officer, Director
- Christopher R. LooseExecutive Officer
- Marc KozinDirector
- Robert LangerDirector
- Marc CohenDirector
- Timothy BarberichDirector
- Offering amount
- $32M
- Amount sold
- $32M
- First sale
- Mar 2017
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
4 people who came through Frequency Therapeutics went on to found or lead other companies.
Frequently asked questions
- Who founded Frequency Therapeutics?
- Frequency Therapeutics was founded by David Lucchino, Christopher R. Loose in 2014.
- Who are Frequency Therapeutics's investors?
- Frequency Therapeutics's investors include venBio Partners, Alexandria, Axil Capital, Kendall Capital Partners, Taiwania Capital.
- How much funding has Frequency Therapeutics raised?
- Frequency Therapeutics has disclosed $136.3M raised across 3 of its 4 known rounds.
- Where is Frequency Therapeutics headquartered?
- Frequency Therapeutics is headquartered in Woburn, US.